
Alkermes PLC (NASDAQ: ALKS) was started as Outperform with a $57 price target at Credit Suisse.
Apollo Education Group Inc. (NASDAQ: APOL) traded lower after earnings, but the for-profit education player’s shares were upgraded to Outperform from Market Perform at Wells Fargo. Zacks said Tuesday night that its rating was slipping to a Strong Sell rating.
ArcelorMittal (NYSE: MT) was downgraded to Neutral from Outperform at Credit Suisse.
Cognizant Technology Solutions Corp. (NASDAQ: CTSH) was raised to Buy from Neutral at UBS.
Comerica Inc. (NYSE: CMA) was raised to Market Perform from Underperform at Wells Fargo.
Edison International (NYSE: EIX) was downgraded to Hold from Buy at Argus in a valuation call.
READ ALSO: Can MannKind Double Again After FDA Approval?
Essex Property Trust Inc. (NYSE: ESS) was downgraded to Neutral from Buy at Goldman Sachs.
Ford Motor Co. (NYSE: F) was started as Neutral at Nomura.
General Motors Co. (NYSE: GM) was started as Reduce at Nomura.
Goldman Sachs Group Inc. (NYSE: GS) was reiterated as Outperform with a $185 price target (versus a $165.92 close) at Credit Suisse, but the firm lowered its 2014 earnings expectations by almost 3% due to elevated litigation expenses.
READ ALSO: Pacific Ethanol Ready for New Highs
Imperial Oil Ltd. (NYSE: IMO) was downgraded to Underperform from Neutral at Bank of America Merrill Lynch.
Intuitive Surgical Inc. (NASDAQ: ISRG) is getting a serious upgrade after its robotic device was granted FDA approval. JMP Securities is taking its rating up to Outperform from Underperform, and the price target was more than doubled — to $700 from $320 — making it the highest of all price targets among the two-dozen or so analysts that follow it. Its stock was up 12.7% to $493.60 on Tuesday, against a 52-week range of $351.14 to $516.07.
Medicines Co. (NASDAQ: MDCO) was downgraded to Neutral from Overweight at Piper Jaffray, and the price target was slashed to $29 from $41 after Tuesday’s big drop.
Textron Inc. (NYSE: TXT) was started as Overweight with a $44 price target at J.P. Morgan.